BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32201176)

  • 1. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
    Goldner D; Lavine JE
    Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease in Children.
    Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
    Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease.
    Vittorio J; Lavine JE
    F1000Res; 2020; 9():. PubMed ID: 32509277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
    Younossi ZM
    Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.
    Petta S; Ting J; Saragoni S; Degli Esposti L; Shreay S; Petroni ML; Marchesini G;
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):1014-1022. PubMed ID: 32423665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
    Cotter TG; Rinella M
    Gastroenterology; 2020 May; 158(7):1851-1864. PubMed ID: 32061595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Approach a Patient With Nonalcoholic Fatty Liver Disease.
    Tilg H
    Gastroenterology; 2017 Aug; 153(2):345-349. PubMed ID: 28647352
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.
    Hassan K; Bhalla V; El Regal ME; A-Kader HH
    World J Gastroenterol; 2014 Sep; 20(34):12082-101. PubMed ID: 25232245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.
    Goyal NP; Schwimmer JB
    Clin Liver Dis; 2016 May; 20(2):325-38. PubMed ID: 27063272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Roeb E; Geier A
    Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis.
    Li B; Zhang C; Zhan YT
    Can J Gastroenterol Hepatol; 2018; 2018():2784537. PubMed ID: 30065915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies.
    Agyapong G; Dashti F; Banini BA
    Ann N Y Acad Sci; 2023 Aug; 1526(1):16-29. PubMed ID: 37400359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease.
    Tzifi F; Fretzayas A; Chrousos G; Kanaka-Gantenbein C
    Hormones (Athens); 2019 Sep; 18(3):255-265. PubMed ID: 31140156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.